These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 16144563)
1. [Controlled live dendritic cell vaccine mediates potent antitumor immune responses]. Kang Y; Xu CJ; Liu XS; Zhang XH; Wu CQ; Zhong CP; Gu JR Zhonghua Fu Chan Ke Za Zhi; 2004 Oct; 39(10):669-74. PubMed ID: 16144563 [TBL] [Abstract][Full Text] [Related]
2. [Herpes simplex virus type 1 thymidine kinase/ganciclovir (HSV(1)-TK/GCV) system as an effective "in vivo death switch" of live tumor vaccines]. Kang Y; Xu CJ; Liu XS; Wu CQ; Zhong CP; Gu JR Ai Zheng; 2005 Aug; 24(8):909-14. PubMed ID: 16086864 [TBL] [Abstract][Full Text] [Related]
3. [Suicidal cancer vaccine enhances anti-tumor immunotherapeutic effect and its safety in the treatment of ovarian cancer]. Kang Y; Xu CJ; Liu XS; Shao ZM; Ou ZL; Luo JM; Wu CQ; Zhong CP; Gu JR Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):654-7. PubMed ID: 17274368 [TBL] [Abstract][Full Text] [Related]
4. A novel strategy to compensate the disadvantages of live vaccine using suicide-gene system and provide better antitumor immunity. Kang Y; Xu CJ; Wu CQ; Liu XS; Zhong CP; Zhang XH; Qiao SY; Gu JR Vaccine; 2006 Mar; 24(12):2141-50. PubMed ID: 16368168 [TBL] [Abstract][Full Text] [Related]
5. Expression of costimulatory molecules: B7 and ICAM up-regulation after treatment with a suicide gene. Ramesh R; Munshi A; Abboud CN; Marrogi AJ; Freeman SM Cancer Gene Ther; 1996; 3(6):373-84. PubMed ID: 8988840 [TBL] [Abstract][Full Text] [Related]
6. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen. Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645 [TBL] [Abstract][Full Text] [Related]
7. Conditional ablation of dendritic cells in transgenic mice. Salomon B; Lorès P; Pioche C; Racz P; Jami J; Klatzmann D J Immunol; 1994 Jan; 152(2):537-48. PubMed ID: 8283035 [TBL] [Abstract][Full Text] [Related]
8. [Anti-metastatic effect of vascular endothelial growth factor receptor 2 extracellular domain gene-modified dendritic cell vaccination in murine model with experimental pulmonary metastasis]. Pan JP; Weng YS; Wu QQ Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):646-9. PubMed ID: 17274366 [TBL] [Abstract][Full Text] [Related]
9. Characteristics of ovarian cancer cells transduced by the bicistronic retroviral vector containing GM-CSF and HSV-TK genes. Guan J; Ma L; Wei L Chin Med J (Engl); 2001 Feb; 114(2):147-51. PubMed ID: 11780195 [TBL] [Abstract][Full Text] [Related]
10. [Experimental studies on the characteristics of suicide gene system HSV-tk/GCV and its effect on dendritic cells]. Wang X; Li L; Feng K; Bai L; Pei X Zhonghua Xue Ye Xue Za Zhi; 2000 Dec; 21(12):628-31. PubMed ID: 11877036 [TBL] [Abstract][Full Text] [Related]
11. [Studies on herpes simplex virus thymidine kinase gene and GCV system for treatment of human bladder carcinoma]. He J; Chen Y; Li H; Lu Y; Yan Y; Tan X Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Jun; 21(3):428-32. PubMed ID: 15250149 [TBL] [Abstract][Full Text] [Related]
12. [Experimental study of dually targeting gene therapy system for pituitary adenomas]. Ma CY; Lu YC; Shi JX; Ren CC; Zhu JD; Gu JR Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(4):262-6. PubMed ID: 15854489 [TBL] [Abstract][Full Text] [Related]
13. Cancer-specific targeting of an adenovirus-delivered herpes simplex virus thymidine kinase suicide gene using translational control. Mathis JM; Williams BJ; Sibley DA; Carroll JL; Li J; Odaka Y; Barlow S; Nathan CO; Li BD; DeBenedetti A J Gene Med; 2006 Sep; 8(9):1105-20. PubMed ID: 16802401 [TBL] [Abstract][Full Text] [Related]
14. Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines. Wang J; Saffold S; Cao X; Krauss J; Chen W J Immunol; 1998 Nov; 161(10):5516-24. PubMed ID: 9820528 [TBL] [Abstract][Full Text] [Related]
16. Herpes simplex virus thymidine kinase/ganciclovir-mediated killing of tumor cell induces tumor-specific cytotoxic T cells in mice. Yamamoto S; Suzuki S; Hoshino A; Akimoto M; Shimada T Cancer Gene Ther; 1997; 4(2):91-6. PubMed ID: 9080117 [TBL] [Abstract][Full Text] [Related]
17. [In vitro treatment of ovarian cancer cells with cytosine deaminase-thymidine kinase fusion disuicide gene therapy system under the control of human telomerase reverse transcriptase gene promoter]. Kong BH; Song Y; Ma DX; Qu X; Jiang S Zhonghua Fu Chan Ke Za Zhi; 2004 Jun; 39(6):390-5. PubMed ID: 15312323 [TBL] [Abstract][Full Text] [Related]
18. Enhanced HER-2/neu-specific antitumor immunity by cotransduction of mouse dendritic cells with two genes encoding HER-2/neu and alpha tumor necrosis factor. Chen Z; Huang H; Chang T; Carlsen S; Saxena A; Marr R; Xing Z; Xiang J Cancer Gene Ther; 2002 Sep; 9(9):778-86. PubMed ID: 12189528 [TBL] [Abstract][Full Text] [Related]
19. Suicide gene therapy of ovarian cancer: an experimental study in rats using retroviral-mediated transfer of herpes simplex virus thymidine kinase gene. Nagy HJ; Panis Y; Fabre M; Klatzmann D; Houssin D; Soubrane O Anticancer Res; 2000; 20(6B):4633-8. PubMed ID: 11205314 [TBL] [Abstract][Full Text] [Related]
20. Retrovirus-mediated gene therapy of experimental brain neoplasms using the herpes simplex virus-thymidine kinase/ganciclovir paradigm. Rainov NG; Kramm CM; Aboody-Guterman K; Chase M; Ueki K; Louis DN; Harsh GR; Chiocca A; Breakefield XO Cancer Gene Ther; 1996; 3(2):99-106. PubMed ID: 8729908 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]